Metropolitan Life Insurance Company (MetLife)’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-28,609
Closed -$25.3K 2520
2022
Q4
$25.3K Buy
28,609
+11,028
+63% +$9.77K ﹤0.01% 1874
2022
Q3
$27.6K Sell
17,581
-5,501
-24% -$8.64K ﹤0.01% 1838
2022
Q2
$46.4K Buy
23,082
+3,901
+20% +$7.84K ﹤0.01% 1553
2022
Q1
$44.7K Sell
19,181
-58,256
-75% -$136K ﹤0.01% 1658
2021
Q4
$360K Buy
77,437
+4,537
+6% +$21.1K ﹤0.01% 1629
2021
Q3
$556K Sell
72,900
-519
-0.7% -$3.96K 0.01% 1386
2021
Q2
$711K Buy
73,419
+5,803
+9% +$56.2K 0.01% 1273
2021
Q1
$559K Sell
67,616
-3,915
-5% -$32.4K 0.01% 1347
2020
Q4
$488K Buy
71,531
+7,034
+11% +$48K 0.01% 1365
2020
Q3
$719K Buy
64,497
+9,756
+18% +$109K 0.01% 947
2020
Q2
$344K Buy
54,741
+10,837
+25% +$68.1K 0.01% 1467
2020
Q1
$80.8K Buy
43,904
+1,182
+3% +$2.18K ﹤0.01% 2165
2019
Q4
$144K Buy
42,722
+23,131
+118% +$78.2K ﹤0.01% 2122
2019
Q3
$41.9K Sell
19,591
-13,546
-41% -$29K ﹤0.01% 2511
2019
Q2
$88.5K Hold
33,137
﹤0.01% 2369
2019
Q1
$157K Buy
33,137
+2,926
+10% +$13.9K ﹤0.01% 2060
2018
Q4
$72.5K Hold
30,211
﹤0.01% 2470
2018
Q3
$133K Hold
30,211
﹤0.01% 2286
2018
Q2
$218K Buy
+30,211
New +$218K ﹤0.01% 1890
2016
Q2
Sell
-24,810
Closed -$133K 2700
2016
Q1
$133K Buy
24,810
+4,569
+23% +$24.5K ﹤0.01% 2384
2015
Q4
$176K Hold
20,241
﹤0.01% 2343
2015
Q3
$170K Sell
20,241
-708
-3% -$5.95K ﹤0.01% 2393
2015
Q2
$369K Buy
+20,949
New +$369K ﹤0.01% 1961